Mariana J. Shayo

Mariana J. Shayo

Auto-generated profile, based on publicly available information

Mariana J. Shayo

Department of Biomedical Science, School of Public Health, KCMC University, Moshi, Tanzania; Kilimanjaro Clinical Research Institute, Moshi, Tanzania; Department of Biological and Pre-Clinical Studies, Muhimbili University of Health and Allied Sciences, Tanzania

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2022 in Heliyon
Verified
Journal Article
Open access
JMJoseph Malakalinga
Joseph Malakalinga
GMGerald Misinzo
Gerald Misinzo
GMGeorge M. Msalya
George M. Msalya
MSMariana J. Shayo
Mariana J. Shayo
RKRudovick R. Kazwala
Rudovick R. Kazwala
Animals have been identified as the potential reservoirs of rotavirus group A (RVA) for human infection. However, very little is known regarding the genotype and genomic profiles of circulating RVA in Tanzanian piglets. The rotavirus genetic diversity and genome analysis was assessed among piglets from Southern highlands and Eastern Tanzania. A total of 241 faecal samples were collected from piglets in the regions of Mbeya, Iringa, and Morogoro. RVA was detected and genotyped using reverse transcription polymerase chain reaction (RT-PCR). Sanger dideoxynucleotide cycle sequencing of the viral protein (VP) 4 and VP7 genes was afterwards performed to confirm the RT-PCR results. Selected genotypes were subjected to whole genome sequencing. The overall prevalence of RVA was 35.26% (85/241) in piglets (30.58% in Mbeya, 43.75% in Iringa and 31.16% in Morogoro). Upon genotyping, the G genotypes were G4 (26), G9 (10), G3 (6), G5 (3) and the remaining 40 were untypeable, while the P genotype, were P[6] (35), P[13] (3) and the remaining 47 were untypeable. The G4P[6] were the predominant genotype followed by G3P[6], G3P[13], G4P[13] and G5P[13] were most common genotypes combinations. On phylogenetic analysis, G4 was grouped to lineage V, sublineages VIIa and VIIc, G9 to lineage I, G5 to lineage II, G3 to lineage IV, P[6] to lineage V and sublineage Ic and the P[13] to lineage IV. We revealed amino acid differences between the circulating G4 and the G4 in the ProSystems RCE vaccine used in pigs. The whole genome reveals genomic constellation of G4-P[6]-I1-R1-C1-M1-A8-N1-T1-E1-H1, G5-P[x]-I5-R1-C1-M1-A8-N1-Tx-E1-H1, G3/G4-P[13]/P[6]-Ix-R1-C1-M1-A8-N1-T1-E1-H1, G3-P[6]-Ix-R1-C1-M1-A8-N1-Tx-E1-H1 and G9-P[x]-Ix-R1-C1-M1-Ax-N1-Tx-E1-H1. The VP7 gene of G9, the VP4 gene of P[6] and NSP4 (E1) gene of some genotypes clustered together and closely related to humans origin or porcine-human reassortant strains with nucleotide similarities ranging from 97.90% to 99.74% from neighboring countries, implying possibility intragenogroup reassortment and interspecies transmission. The higher strain diversity observed within the gene segments highlight the importance of genomic analysis and continuous monitoring of RVA genotypes. Further research is needed to determine the risk factors associated with RVA infection in Tanzanian pigs in order to properly design a control program.

27 June 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
MSMariana J. Shayo
Mariana J. Shayo
BSBaraka Samwel
Baraka Samwel
DSDaniel M. Shadrack
Daniel M. Shadrack
JCJoel Cassel Joel Cassel
Joel Cassel Joel Cassel
JSJoseph Salvino
Joseph Salvino
EIEster Innocent
Ester Innocent
The coronavirus disease 2019 (COVID-19) has spread worldwide with severe health, social, and economic repercussions. Although vaccines have significantly reduced the severity of symptoms and deaths, alternative medications derived from natural products (NPs) are vital to further decrease fatalities, especially in regions with low vaccine uptake. When paired with the latest computational developments, NPs, which have been used to cure illnesses and infections for thousands of years, constitute a renewed resource for drug discovery. In the present report, a combination of computational and in vitro methods reveals the repositioning of NPs and identifies salvinorin A and deacetylgedunin (DCG) as having potential anti-SARS-CoV-2 activities. Salvinorin A was found both in silico and in vitro to inhibit both SARS-CoV-2 spike/host ACE2 protein interactions, consistent with blocking viral cell entry, and well as live virus replication. Plant extracts from Azadirachta indica and Cedrela odorata, which contain high levels of DCG, inhibited viral cell replication by targeting the main protease (Mpro) and/or inhibited viral cell entry by blocking the interaction between spike RBD–ACE2 protein at concentrations lower than salvinorin A. Our findings suggest that salvinorin A represent promising chemical starting points where further optimization may result in effective natural product-derived and potent anti-SARS-CoV-2 inhibitors to supplement vaccine efforts.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
HKHappiness Houka Kumburu
Happiness Houka Kumburu
MSMariana J. Shayo
Mariana J. Shayo
MZMarco van Zwetselaar
Marco van Zwetselaar
JNJudith Njau
Judith Njau
Davis KuchakaDavis Kuchaka
Davis Kuchaka
TSTolbert Sonda
Tolbert Sonda
In resource-limited settings, patients are often first presented to clinical settings when seriously ill and the access to proper clinical microbial diagnostic is often very limited or non-existing. On February 16th 2022 we were on a field trip to test a completely field-deployable metagenomics sequencing set-up, including DNA purification, sequencing and bioinformatics analyses on a lap-top analyses on water samples, just outside Moshi, Tanzania. On our way to the test site, we were contacted by the nearby Machame hospital regarding a child seriously ill with diarrhea and not responding to treatment. Within the same day we conducted an onsite metagenomics examination of a fecal sample from the child using and were able to identify the causative agent as Campylobacter jejuni. The treatment was subsequently changed, with almost immediate improvement and the child discharged on February 21st,

23 January 2026 in Virology
Verified
Journal Article
Open access
MSMariana J. Shayo
Mariana J. Shayo
Davis KuchakaDavis Kuchaka
Davis Kuchaka
MBMelkiory Beti
Melkiory Beti
PKPatrick Kimu
Patrick Kimu
BWBoaz Wadugu
Boaz Wadugu
TSTolbert Sonda
Tolbert Sonda
Human adenoviruses (HAdVs) are important pathogens that are associated with a wide array of clinical diseases, particularly in the pediatric population. Despite numerous reports of HAdV infections in Tanzania, there are currently no whole genome sequences from this region available in global public databases. This gap presents challenges to our efforts to understand their dissemination and evolution over time. This study employed nanopore-based metagenomic sequencing to detect and sequence the whole genomes of HAdV strains in Tanzanian infants with diarrhea. We present the first whole genome of HAdV-A18 from Africa, representing only the third worldwide. Additionally, it includes the first complete genomes of HAdV-F40, HAdV-F41, and HAdV-B3 obtained from Tanzania. In addition, this study provides information on the enteric adenovirus lineages circulating in Tanzania. These findings provide crucial genomic insights into the diversity of viruses in sub-Saharan Africa and underscore the importance of genomic surveillance to deepen our understanding of adenovirus transmission and evolution.

3 March 2026 in Virology
Verified
Journal Article
Closed access
MSMariana J. Shayo
Mariana J. Shayo
Davis KuchakaDavis Kuchaka
Davis Kuchaka
MBMelkiory Beti
Melkiory Beti
GMGerald Phares Mwing'A
Gerald Phares Mwing'A
PKPatrick Kimu
Patrick Kimu
TSTolbert Sonda
Tolbert Sonda

10 July 2026 in Virology
Verified
Journal Article
Closed access
MSMariana J. Shayo
Mariana J. Shayo
Davis KuchakaDavis Kuchaka
Davis Kuchaka
MBMelkiory Beti
Melkiory Beti
PKPatrick Kimu
Patrick Kimu
BWBoaz Wadugu
Boaz Wadugu
TSTolbert Sonda
Tolbert Sonda